Osaic Holdings’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Other funds holding DNTH
Osaic Holdings's DNTH Position: Q3 2026 in Review
Osaic Holdings increased its Dianthus Therapeutics (DNTH) stake by 3,085% in Q3 2026, buying an estimated $41.6K and bringing the position to 414 shares worth $36.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5752.
Osaic Holdings first reported a position in DNTH in Q3 2020 and has held it in 14 quarters since. The position peaked at $85.2K in Q3 2024. 275 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.
- Osaic Holdings held 414 shares of Dianthus Therapeutics worth $36.3K as of Q3 2026.
- Osaic Holdings bought 401 Dianthus Therapeutics shares in Q3 2026, an estimated $41.6K.
- Dianthus Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #5752 holding.
- Osaic Holdings first reported a position in Dianthus Therapeutics in Q3 2020 and has held it in 14 quarters since.
- Osaic Holdings's Dianthus Therapeutics position peaked at $85.2K in Q3 2024.
- 275 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.
Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.